3B96 - JenaLib

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Title :   STRUCTURAL BASIS FOR SUBSTRATE FATTY-ACYL CHAIN SPECIFICITY: CRYSTAL STRUCTURE OF HUMAN VERY-LONG-CHAIN ACYL-COA DEHYDROGENASE

Authors :   R. P. Mcandrew, Y. Wang, A. W. Mohsen, M. He, J. Vockley, J. J. Kim

Date :   02 Nov 07 (Deposition) - 12 Feb 08 (Release) - 09 Jun 09 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   1.91

Chains :   Asym. Unit : A
Biol. Unit 1: A  (2x)

Keywords :   Acyl-Coa, Fatty Acid Beta-Oxidation, Dehydrogenase, Very Long Chain, Mitochondria, Membrane, Acetylation, Alternative Splicing, Cardiomyopathy, Disease Mutation, Fad, Fatty Acid Metabolism, Flavoprotein, Lipid Metabolism, Mitochondrion, Oxidoreductase, Polymorphism, Transit Peptide, Ubl Conjugation (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   R. P. Mcandrew, Y. Wang, A. W. Mohsen, M. He, J. Vockley, J. J. Kim
Structural Basis For Substrate Fatty Acyl Chain Specificity: Crystal Structure Of Human Very-Long-Chain Acyl-Coa Dehydrogenase.
J. Biol. Chem. V. 283 9435 2008
PubMed-ID: 18227065 | Reference-DOI: 10.1074/JBC.M709135200
(for further references see the PDB file header)

Molecule 1 - VERY LONG-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE
	Chains	:	A
	EC Number	:	1.3.99.-
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI BL21(DE3)
	Expression System Plasmid	:	PET-21A
	Expression System Strain	:	BL21(DE3)
	Expression System Taxid	:	469008
	Expression System Vector Type	:	PLASMID
	Gene	:	ACADVL, VLCAD
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	VLCAD

		1
Asymmetric Unit	:	A
Biological Unit 1 (2x)	:	A

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (2, 2)

No.	Name	Count	Type	Full Name
1	FAD	1	Ligand/Ion	FLAVIN-ADENINE DINUCLEOTIDE
2	MYA	1	Ligand/Ion	TETRADECANOYL-COA

Biological Unit 1 (2, 4)

No.	Name	Count	Type	Full Name
1	FAD	2	Ligand/Ion	FLAVIN-ADENINE DINUCLEOTIDE
2	MYA	2	Ligand/Ion	TETRADECANOYL-COA

Asymmetric Unit (2, 2)

No.	Name	Evidence	Residues	Description
1	AC1	SOFTWARE	TYR A:120 , VAL A:124 , GLY A:135 , ILE A:144 , LEU A:297 , PHE A:421 , GLU A:422 , GLY A:423 , FAD A:616 , HOH A:1002	BINDING SITE FOR RESIDUE MYA A 1
2	AC2	SOFTWARE	MYA A:1 , PHE A:174 , LEU A:176 , THR A:177 , GLY A:182 , SER A:183 , TRP A:209 , ILE A:210 , SER A:211 , ARG A:326 , GLN A:328 , PHE A:329 , ILE A:333 , PHE A:336 , GLN A:395 , ILE A:396 , GLY A:399 , ILE A:417 , PHE A:421 , THR A:424 , ASP A:426 , ILE A:427 , GLN A:522 , HOH A:639 , HOH A:654 , HOH A:668 , HOH A:680	BINDING SITE FOR RESIDUE FAD A 616

(no "SS Bond" information available for 3B96)

Asymmetric Unit

No.	Residues
1	Phe A:48	-	Pro A:49

Asymmetric Unit (37, 37)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_000332	T	158	N	ACADV_HUMAN	Disease (ACADVLD)	---	A	T	118	N
02	UniProt	VAR_000333	Q	159	R	ACADV_HUMAN	Disease (ACADVLD)	746688190	A	Q	119	R
03	UniProt	VAR_000334	V	174	M	ACADV_HUMAN	Disease (ACADVLD)	369560930	A	V	134	M
04	UniProt	VAR_000335	G	185	S	ACADV_HUMAN	Disease (ACADVLD)	545215807	A	G	145	S
05	UniProt	VAR_010101	A	213	P	ACADV_HUMAN	Disease (ACADVLD)	140629318	A	A	173	P
06	UniProt	VAR_000336	E	218	K	ACADV_HUMAN	Disease (ACADVLD)	---	A	E	178	K
07	UniProt	VAR_000337	L	243	R	ACADV_HUMAN	Disease (ACADVLD)	---	A	L	203	R
08	UniProt	VAR_010102	K	247	E	ACADV_HUMAN	Disease (ACADVLD)	---	A	K	207	E
09	UniProt	VAR_000338	K	247	T	ACADV_HUMAN	Disease (ACADVLD)	---	A	K	207	T
10	UniProt	VAR_000339	T	260	M	ACADV_HUMAN	Disease (ACADVLD)	113994168	A	T	220	M
11	UniProt	VAR_000341	A	281	D	ACADV_HUMAN	Disease (ACADVLD)	---	A	A	241	D
12	UniProt	VAR_000342	V	283	A	ACADV_HUMAN	Disease (ACADVLD)	113994167	A	V	243	A
13	UniProt	VAR_000343	G	290	D	ACADV_HUMAN	Disease (ACADVLD)	866464446	A	G	250	D
14	UniProt	VAR_000344	G	294	E	ACADV_HUMAN	Disease (ACADVLD)	200573371	A	G	254	E
15	UniProt	VAR_000345	K	299	N	ACADV_HUMAN	Disease (ACADVLD)	774716484	A	K	259	N
16	UniProt	VAR_000347	V	317	A	ACADV_HUMAN	Disease (ACADVLD)	398123095	A	V	277	A
17	UniProt	VAR_000348	M	352	V	ACADV_HUMAN	Disease (ACADVLD)	---	A	M	312	V
18	UniProt	VAR_011990	A	359	S	ACADV_HUMAN	Polymorphism	1051701	A	A	319	S
19	UniProt	VAR_000349	R	366	C	ACADV_HUMAN	Disease (ACADVLD)	771874163	A	R	326	C
20	UniProt	VAR_000350	R	366	H	ACADV_HUMAN	Disease (ACADVLD)	112406105	A	R	326	H
21	UniProt	VAR_000352	K	382	Q	ACADV_HUMAN	Disease (ACADVLD)	118204015	A	K	342	Q
22	UniProt	VAR_000353	D	405	H	ACADV_HUMAN	Disease (ACADVLD)	---	A	D	365	H
23	UniProt	VAR_000354	G	441	D	ACADV_HUMAN	Disease (ACADVLD)	2309689	A	G	401	D
24	UniProt	VAR_000355	R	450	H	ACADV_HUMAN	Disease (ACADVLD)	118204016	A	R	410	H
25	UniProt	VAR_000356	R	453	Q	ACADV_HUMAN	Disease (ACADVLD)	138058572	A	R	413	Q
26	UniProt	VAR_000357	D	454	N	ACADV_HUMAN	Disease (ACADVLD)	---	A	D	414	N
27	UniProt	VAR_000358	R	456	H	ACADV_HUMAN	Disease (ACADVLD)	794727112	A	R	416	H
28	UniProt	VAR_010103	F	458	L	ACADV_HUMAN	Disease (ACADVLD)	118204017	A	F	418	L
29	UniProt	VAR_000359	R	459	W	ACADV_HUMAN	Disease (ACADVLD)	766742117	A	R	419	W
30	UniProt	VAR_000360	G	463	E	ACADV_HUMAN	Disease (ACADVLD)	200366828	A	G	423	E
31	UniProt	VAR_000361	R	469	Q	ACADV_HUMAN	Disease (ACADVLD)	398123083	A	R	429	Q
32	UniProt	VAR_000362	R	469	W	ACADV_HUMAN	Disease (ACADVLD)	113994170	A	R	429	W
33	UniProt	VAR_010105	E	534	K	ACADV_HUMAN	Disease (ACADVLD)	2230180	A	E	494	K
34	UniProt	VAR_000364	L	602	I	ACADV_HUMAN	Disease (ACADVLD)	---	A	L	562	I
35	UniProt	VAR_000365	R	613	W	ACADV_HUMAN	Disease (ACADVLD)	118204014	A	R	573	W
36	UniProt	VAR_010106	R	615	Q	ACADV_HUMAN	Disease (ACADVLD)	148584617	A	R	575	Q
37	UniProt	VAR_011991	S	623	F	ACADV_HUMAN	Polymorphism	13383	A	S	583	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (37, 74)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_000332	T	158	N	ACADV_HUMAN	Disease (ACADVLD)	---	A	T	118	N
02	UniProt	VAR_000333	Q	159	R	ACADV_HUMAN	Disease (ACADVLD)	746688190	A	Q	119	R
03	UniProt	VAR_000334	V	174	M	ACADV_HUMAN	Disease (ACADVLD)	369560930	A	V	134	M
04	UniProt	VAR_000335	G	185	S	ACADV_HUMAN	Disease (ACADVLD)	545215807	A	G	145	S
05	UniProt	VAR_010101	A	213	P	ACADV_HUMAN	Disease (ACADVLD)	140629318	A	A	173	P
06	UniProt	VAR_000336	E	218	K	ACADV_HUMAN	Disease (ACADVLD)	---	A	E	178	K
07	UniProt	VAR_000337	L	243	R	ACADV_HUMAN	Disease (ACADVLD)	---	A	L	203	R
08	UniProt	VAR_010102	K	247	E	ACADV_HUMAN	Disease (ACADVLD)	---	A	K	207	E
09	UniProt	VAR_000338	K	247	T	ACADV_HUMAN	Disease (ACADVLD)	---	A	K	207	T
10	UniProt	VAR_000339	T	260	M	ACADV_HUMAN	Disease (ACADVLD)	113994168	A	T	220	M
11	UniProt	VAR_000341	A	281	D	ACADV_HUMAN	Disease (ACADVLD)	---	A	A	241	D
12	UniProt	VAR_000342	V	283	A	ACADV_HUMAN	Disease (ACADVLD)	113994167	A	V	243	A
13	UniProt	VAR_000343	G	290	D	ACADV_HUMAN	Disease (ACADVLD)	866464446	A	G	250	D
14	UniProt	VAR_000344	G	294	E	ACADV_HUMAN	Disease (ACADVLD)	200573371	A	G	254	E
15	UniProt	VAR_000345	K	299	N	ACADV_HUMAN	Disease (ACADVLD)	774716484	A	K	259	N
16	UniProt	VAR_000347	V	317	A	ACADV_HUMAN	Disease (ACADVLD)	398123095	A	V	277	A
17	UniProt	VAR_000348	M	352	V	ACADV_HUMAN	Disease (ACADVLD)	---	A	M	312	V
18	UniProt	VAR_011990	A	359	S	ACADV_HUMAN	Polymorphism	1051701	A	A	319	S
19	UniProt	VAR_000349	R	366	C	ACADV_HUMAN	Disease (ACADVLD)	771874163	A	R	326	C
20	UniProt	VAR_000350	R	366	H	ACADV_HUMAN	Disease (ACADVLD)	112406105	A	R	326	H
21	UniProt	VAR_000352	K	382	Q	ACADV_HUMAN	Disease (ACADVLD)	118204015	A	K	342	Q
22	UniProt	VAR_000353	D	405	H	ACADV_HUMAN	Disease (ACADVLD)	---	A	D	365	H
23	UniProt	VAR_000354	G	441	D	ACADV_HUMAN	Disease (ACADVLD)	2309689	A	G	401	D
24	UniProt	VAR_000355	R	450	H	ACADV_HUMAN	Disease (ACADVLD)	118204016	A	R	410	H
25	UniProt	VAR_000356	R	453	Q	ACADV_HUMAN	Disease (ACADVLD)	138058572	A	R	413	Q
26	UniProt	VAR_000357	D	454	N	ACADV_HUMAN	Disease (ACADVLD)	---	A	D	414	N
27	UniProt	VAR_000358	R	456	H	ACADV_HUMAN	Disease (ACADVLD)	794727112	A	R	416	H
28	UniProt	VAR_010103	F	458	L	ACADV_HUMAN	Disease (ACADVLD)	118204017	A	F	418	L
29	UniProt	VAR_000359	R	459	W	ACADV_HUMAN	Disease (ACADVLD)	766742117	A	R	419	W
30	UniProt	VAR_000360	G	463	E	ACADV_HUMAN	Disease (ACADVLD)	200366828	A	G	423	E
31	UniProt	VAR_000361	R	469	Q	ACADV_HUMAN	Disease (ACADVLD)	398123083	A	R	429	Q
32	UniProt	VAR_000362	R	469	W	ACADV_HUMAN	Disease (ACADVLD)	113994170	A	R	429	W
33	UniProt	VAR_010105	E	534	K	ACADV_HUMAN	Disease (ACADVLD)	2230180	A	E	494	K
34	UniProt	VAR_000364	L	602	I	ACADV_HUMAN	Disease (ACADVLD)	---	A	L	562	I
35	UniProt	VAR_000365	R	613	W	ACADV_HUMAN	Disease (ACADVLD)	118204014	A	R	573	W
36	UniProt	VAR_010106	R	615	Q	ACADV_HUMAN	Disease (ACADVLD)	148584617	A	R	575	Q
37	UniProt	VAR_011991	S	623	F	ACADV_HUMAN	Polymorphism	13383	A	S	583	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (2, 2)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ACYL_COA_DH_1	PS00072	Acyl-CoA dehydrogenases signature 1.	ACADV_HUMAN	215-227	1	A:175-187
2	ACYL_COA_DH_2	PS00073	Acyl-CoA dehydrogenases signature 2.	ACADV_HUMAN	435-454	1	A:395-414

Biological Unit 1 (2, 4)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	ACYL_COA_DH_1	PS00072	Acyl-CoA dehydrogenases signature 1.	ACADV_HUMAN	215-227	2	A:175-187
2	ACYL_COA_DH_2	PS00073	Acyl-CoA dehydrogenases signature 2.	ACADV_HUMAN	435-454	2	A:395-414

Asymmetric Unit (18, 18)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000356839	1a	ENSE00001486705	chr17:7123131-7123365	235	ACADV_HUMAN	1-67	67	0	-	-
1.2	ENST00000356839	2	ENSE00001150930	chr17:7123441-7123516	76	ACADV_HUMAN	67-92	26	1	A:29-52	24
1.3	ENST00000356839	3	ENSE00001203537	chr17:7123783-7123848	66	ACADV_HUMAN	93-114	22	1	A:53-74	22
1.4	ENST00000356839	4	ENSE00001150924	chr17:7123923-7123995	73	ACADV_HUMAN	115-139	25	1	A:75-99	25
1.5	ENST00000356839	5	ENSE00001150919	chr17:7124085-7124149	65	ACADV_HUMAN	139-160	22	1	A:99-120	22
1.6	ENST00000356839	6	ENSE00001150916	chr17:7124243-7124377	135	ACADV_HUMAN	161-205	45	1	A:121-165	45
1.7	ENST00000356839	7	ENSE00000681054	chr17:7124857-7125001	145	ACADV_HUMAN	206-254	49	1	A:166-214	49
1.8	ENST00000356839	8	ENSE00000887266	chr17:7125271-7125400	130	ACADV_HUMAN	254-297	44	1	A:214-257	44
1.9	ENST00000356839	9	ENSE00000887267	chr17:7125496-7125621	126	ACADV_HUMAN	297-339	43	1	A:257-299	43
1.10	ENST00000356839	10	ENSE00000681061	chr17:7125986-7126184	199	ACADV_HUMAN	339-405	67	1	A:299-365	67
1.11	ENST00000356839	11	ENSE00000681063	chr17:7126452-7126556	105	ACADV_HUMAN	406-440	35	1	A:366-400	35
1.12	ENST00000356839	12	ENSE00000681066	chr17:7126963-7127049	87	ACADV_HUMAN	441-469	29	1	A:401-429	29
1.13	ENST00000356839	13	ENSE00000681068	chr17:7127132-7127194	63	ACADV_HUMAN	470-490	21	1	A:430-445	16
1.14	ENST00000356839	14	ENSE00000681071	chr17:7127287-7127388	102	ACADV_HUMAN	491-524	34	1	A:479-484	6
1.15	ENST00000356839	15	ENSE00000681074	chr17:7127465-7127562	98	ACADV_HUMAN	525-557	33	1	A:485-517	33
1.16	ENST00000356839	16	ENSE00000681076	chr17:7127640-7127712	73	ACADV_HUMAN	557-581	25	1	A:517-541	25
1.17	ENST00000356839	17	ENSE00000681078	chr17:7127799-7127871	73	ACADV_HUMAN	582-606	25	1	A:542-566	25
1.18	ENST00000356839	18	ENSE00000681080	chr17:7127961-7128033	73	ACADV_HUMAN	606-630	25	1	A:566-590	25
1.19	ENST00000356839	19	ENSE00000681082	chr17:7128128-7128203	76	ACADV_HUMAN	630-655	26	1	A:590-615	26
1.20b	ENST00000356839	20b	ENSE00001873164	chr17:7128276-7128587	312	ACADV_HUMAN	656-701	46	0	-	-

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:554
 aligned with ACADV_HUMAN | P49748 from UniProtKB/Swiss-Prot  Length:655

    Alignment length:587
                                    78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328       338       348       358       368       378       388       398       408       418       428       438       448       458       468       478       488       498       508       518       528       538       548       558       568       578       588       598       608       618       628       638       648       
          ACADV_HUMAN    69 ESKSFAVGMFKGQLTTDQVFPYPSVLNEEQTQFLKELVEPVSRFFEEVNDPAKNDALEMVEETTWQGLKELGAFGLQVPSELGGVGLCNTQYARLVEIVGMHDLGVGITLGAHQSIGFKGILLFGTKAQKEKYLPKLASGETVAAFCLTEPSSGSDAASIRTSAVPSPCGKYYTLNGSKLWISNGGLADIFTVFAKTPVTDPATGAVKEKITAFVVERGFGGITHGPPEKKMGIKASNTAEVFFDGVRVPSENVLGEVGSGFKVAMHILNNGRFGMAAALAGTMRGIIAKAVDHATNRTQFGEKIHNFGLIQEKLARMVMLQYVTESMAYMVSANMDQGATDFQIEAAISKIFGSEAAWKVTDECIQIMGGMGFMKEPGVERVLRDLRIFRIFEGTNDILRLFVALQGCMDKGKELSGLGSALKNPFGNAGLLLGEAGKQLRRRAGLGSGLSLSGLVHPELSRSGELAVRALEQFATVVEAKLIKHKKGIVNEQFLLQRLADGAIDLYAMVVVLSRASRSLSEGHPTAQHEKMLCDTWCIEAAARIREGMAALQSDPWQQELYRNFKSISKALVERGGVVTSNPLGF 655
               SCOP domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SCOP domains
               CATH domains 3b96A01               -------------------------------------------------------------------------------------------------------------------------3b96A03 A:172-286 Butyryl-CoA Dehydrogenase, subunit A, domain 2                                                   3b96A01 A:29-50,A:287-445 Butyryl-CoA Dehydrogenase, subunit A, domain 3                                                                                       -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ...hhhhhhhh...............hhhhhhhhhhhhhhhhhhhhhh.hhhhhhhhh..hhhhhhhhhhhh......hhhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhh....eeee........hhhhh..eeee.....eeeeeeeeeeee......eeeeeeeeeee......eeeeeeeeeee.hhh.eee.............eeeeeeeeeeee...ee....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhee..ee...hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh...hhhhhhhhhhhhhh...hhhhhhhhhhhhhhhhhhhhhh---------------------------------.......hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhh.......... Sec.struct. author
             SAPs(SNPs) (1) -----------------------------------------------------------------------------------------NR--------------M----------S---------------------------P----K------------------------R---E------------M--------------------D-A------D---E----N-----------------A----------------------------------V------S------C---------------Q----------------------H-----------------------------------D--------H--QN-H-LW---E-----Q----------------------------------------------------------------K-------------------------------------------------------------------I----------W-Q-------F-------------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------T----------------------------------------------------------------------------------------------------------------------H------------------------------------------------------------------------------------------------------W------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ SAPs(SNPs) (2)
                    PROSITE --------------------------------------------------------------------------------------------------------------------------------------------------ACYL_COA_DH_1---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ACYL_COA_DH_2       --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.2  PDB: A:29-52  Exon 1.3  PDB: A:53-74Exon 1.4  PDB: A:75-99   ---------------------Exon 1.6  PDB: A:121-165 UniProt: 161-205    Exon 1.7  PDB: A:166-214 UniProt: 206-254        ------------------------------------------------------------------------------------Exon 1.10  PDB: A:299-365 UniProt: 339-405                         Exon 1.11  PDB: A:366-400          Exon 1.12  PDB: A:401-429    Exon 1.13            Exon 1.14  PDB: A:479-484         Exon 1.15  PDB: A:485-517        ------------------------Exon 1.17  PDB: A:542-566-----------------------Exon 1.19  PDB: A:590-615  Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------Exon 1.5  PDB: A:99-12---------------------------------------------------------------------------------------------Exon 1.8  PDB: A:214-257 UniProt: 254-297   -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.16  PDB: A:517-541------------------------Exon 1.18  PDB: A:566-590------------------------- Transcript 1 (2)
           Transcript 1 (3) ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.9  PDB: A:257-299 UniProt: 297-339  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Transcript 1 (3)
                 3b96 A  29 ESKSFAVGMFKGQLTTDQVFPYPSVLNEEQTQFLKELVEPVSRFFEEVNDPAKNDALEMVEETTWQGLKELGAFGLQVPSELGGVGLCNTQYARLVEIVGMHDLGVGITLGAHQSIGFKGILLFGTKAQKEKYLPKLASGETVAAFCLTEPSSGSDAASIRTSAVPSPCGKYYTLNGSKLWISNGGLADIFTVFAKTPVTDPATGAVKEKITAFVVERGFGGITHGPPEKKMGIKASNTAEVFFDGVRVPSENVLGEVGSGFKVAMHILNNGRFGMAAALAGTMRGIIAKAVDHATNRTQFGEKIHNFGLIQEKLARMVMLQYVTESMAYMVSANMDQGATDFQIEAAISKIFGSEAAWKVTDECIQIMGGMGFMKEPGVERVLRDLRIFRIFEGTNDILRLFVALQGCMDKGKELS---------------------------------LSLSGLVHPELSRSGELAVRALEQFATVVEAKLIKHKKGIVNEQFLLQRLADGAIDLYAMVVVLSRASRSLSEGHPTAQHEKMLCDTWCIEAAARIREGMAALQSDPWQQELYRNFKSISKALVERGGVVTSNPLGF 615
                                    38        48        58        68        78        88        98       108       118       128       138       148       158       168       178       188       198       208       218       228       238       248       258       268       278       288       298       308       318       328       338       348       358       368       378       388       398       408       418       428       438      |  -         -         -         -|      488       498       508       518       528       538       548       558       568       578       588       598       608       
                                                                                                                                                                                                                                                                                                                                                                                                                                                          445                               479

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 3B96)

(no "Pfam Domain" information available for 3B96)

Asymmetric Unit(hide GO term definitions)

Chain A (ACADV_HUMAN | P49748)

molecular function
	GO:0003995	acyl-CoA dehydrogenase activity	Catalysis of the reaction: acyl-CoA + acceptor = 2,3-dehydroacyl-CoA + reduced acceptor.
	GO:0009055	electron carrier activity	Any molecular entity that serves as an electron acceptor and electron donor in an electron transport chain. An electron transport chain is a process in which a series of electron carriers operate together to transfer electrons from donors to any of several different terminal electron acceptors to generate a transmembrane electrochemical gradient.
	GO:0000062	fatty-acyl-CoA binding	Interacting selectively and non-covalently with acyl-CoA, any derivative of coenzyme A in which the sulfhydryl group is in thiolester linkage with a fatty acyl group.
	GO:0050660	flavin adenine dinucleotide binding	Interacting selectively and non-covalently with FAD, flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes, in either the oxidized form, FAD, or the reduced form, FADH2.
	GO:0004466	long-chain-acyl-CoA dehydrogenase activity	Catalysis of the reaction: acyl-CoA + ETF = 2,3-dehydroacyl-CoA + reduced ETF.
	GO:0016491	oxidoreductase activity	Catalysis of an oxidation-reduction (redox) reaction, a reversible chemical reaction in which the oxidation state of an atom or atoms within a molecule is altered. One substrate acts as a hydrogen or electron donor and becomes oxidized, while the other acts as hydrogen or electron acceptor and becomes reduced.
	GO:0016627	oxidoreductase activity, acting on the CH-CH group of donors	Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces a hydrogen or electron acceptor.
	GO:0052890	oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor	Catalysis of an oxidation-reduction (redox) reaction in which a CH-CH group acts as a hydrogen or electron donor and reduces a flavin.
	GO:0017099	very-long-chain-acyl-CoA dehydrogenase activity	Catalysis of the reaction: acyl-CoA + acceptor = 2,3-dehydroacyl-CoA + reduced acceptor, where the acyl group is a very long chain fatty acid residue. A very long-chain fatty acid is a fatty acid which has a chain length greater than C22.
biological process
	GO:0036498	IRE1-mediated unfolded protein response	A series of molecular signals mediated by the endoplasmic reticulum stress sensor IRE1 (Inositol-requiring transmembrane kinase/endonuclease). Begins with activation of IRE1 in response to endoplasmic reticulum (ER) stress, and ends with regulation of a downstream cellular process, e.g. transcription. One target of activated IRE1 is the transcription factor HAC1 in yeast, or XBP1 in mammals; IRE1 cleaves an intron of a mRNA coding for HAC1/XBP1 to generate an activated HAC1/XBP1 transcription factor, which controls the up regulation of UPR-related genes. At least in mammals, IRE1 can also signal through additional intracellular pathways including JNK and NF-kappaB.
	GO:0015980	energy derivation by oxidation of organic compounds	The chemical reactions and pathways by which a cell derives energy from organic compounds; results in the oxidation of the compounds from which energy is released.
	GO:0030855	epithelial cell differentiation	The process in which a relatively unspecialized cell acquires specialized features of an epithelial cell, any of the cells making up an epithelium.
	GO:0006635	fatty acid beta-oxidation	A fatty acid oxidation process that results in the complete oxidation of a long-chain fatty acid. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and occurs by successive cycles of reactions during each of which the fatty acid is shortened by a two-carbon fragment removed as acetyl coenzyme A; the cycle continues until only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
	GO:0033539	fatty acid beta-oxidation using acyl-CoA dehydrogenase	A fatty acid beta-oxidation pathway in which the initial step of each oxidation cycle, which converts an acyl-CoA to a trans-2-enoyl-CoA, is catalyzed by acyl-CoA dehydrogenase; the electrons removed by oxidation pass through the respiratory chain to oxygen and leave H2O as the product. Fatty acid beta-oxidation begins with the addition of coenzyme A to a fatty acid, and ends when only two or three carbons remain (as acetyl-CoA or propionyl-CoA respectively).
	GO:0006631	fatty acid metabolic process	The chemical reactions and pathways involving fatty acids, aliphatic monocarboxylic acids liberated from naturally occurring fats and oils by hydrolysis.
	GO:0055088	lipid homeostasis	Any process involved in the maintenance of an internal steady state of lipid within an organism or cell.
	GO:0006629	lipid metabolic process	The chemical reactions and pathways involving lipids, compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent. Includes fatty acids; neutral fats, other fatty-acid esters, and soaps; long-chain (fatty) alcohols and waxes; sphingoids and other long-chain bases; glycolipids, phospholipids and sphingolipids; and carotenes, polyprenols, sterols, terpenes and other isoprenoids.
	GO:0008152	metabolic process	The chemical reactions and pathways, including anabolism and catabolism, by which living organisms transform chemical substances. Metabolic processes typically transform small molecules, but also include macromolecular processes such as DNA repair and replication, and protein synthesis and degradation.
	GO:0045717	negative regulation of fatty acid biosynthetic process	Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of fatty acids.
	GO:0046322	negative regulation of fatty acid oxidation	Any process that stops, prevents, or reduces the frequency, rate or extent of fatty acid oxidation.
	GO:0055114	oxidation-reduction process	A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.
	GO:0090181	regulation of cholesterol metabolic process	Any process that modulates the rate, frequency, or extent of cholesterol metabolism, the chemical reactions and pathways involving cholesterol, cholest-5-en-3 beta-ol, the principal sterol of vertebrates and the precursor of many steroids, including bile acids and steroid hormones.
	GO:0001659	temperature homeostasis	A homeostatic process in which an organism modulates its internal body temperature.
	GO:0042760	very long-chain fatty acid catabolic process	The chemical reactions and pathways resulting in the breakdown of a fatty acid which has a chain length greater than C22.
cellular component
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005743	mitochondrial inner membrane	The inner, i.e. lumen-facing, lipid bilayer of the mitochondrial envelope. It is highly folded to form cristae.
	GO:0005759	mitochondrial matrix	The gel-like material, with considerable fine structure, that lies in the matrix space, or lumen, of a mitochondrion. It contains the enzymes of the tricarboxylic acid cycle and, in some organisms, the enzymes concerned with fatty acid oxidation.
	GO:0042645	mitochondrial nucleoid	The region of a mitochondrion to which the DNA is confined.
	GO:0005739	mitochondrion	A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
	GO:0005730	nucleolus	A small, dense body one or more of which are present in the nucleus of eukaryotic cells. It is rich in RNA and protein, is not bounded by a limiting membrane, and is not seen during mitosis. Its prime function is the transcription of the nucleolar DNA into 45S ribosomal-precursor RNA, the processing of this RNA into 5.8S, 18S, and 28S components of ribosomal RNA, and the association of these components with 5S RNA and proteins synthesized outside the nucleolus. This association results in the formation of ribonucleoprotein precursors; these pass into the cytoplasm and mature into the 40S and 60S subunits of the ribosome.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		FAD	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		MYA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
		Phe A:48 - Pro A:49	[ RasMol ]

Biological Unit
	Complete Structure
		Biological Unit 1	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	3b96
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ACADV_HUMAN \| P49748
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	1.3.99.-
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	201475
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ACADV_HUMAN \| P49748
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	ACADV_HUMAN \| P49748	:	2uxw

(no "Related Entries Specified in the PDB File" available for 3B96)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (2, 2)

Sites (2, 2)

SS Bonds (0, 0)

Cis Peptide Bonds (1, 1)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (37, 37)

PROSITE Motifs (2, 2)

Exons (18, 18)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (2, 2)

Pfam Domains (0, 0)

Gene Ontology (32, 32)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File